Storys aus England

Filtern
  • 27.07.2017 – 15:04

    LEO Pharma

    LEO Pharma Ranks Second in Global Clinical Trials Transparency Audit

    Ballerup, Denmark and Hurley, England (ots/PRNewswire) - New top 50 list ranks LEO Pharma in second position, leading the global pharma industry in commitments to increase access to clinical trials information (Logo: http://photos.prnewswire.com/prnh/20130221/595427 ) The AllTrials audit on clinical trial transparency findings has been published ranking LEO Pharma as leaders in the industry. LEO Pharma is ranked at number ...

  • 19.06.2017 – 01:03

    Jaguar Land Rover Deutschland GmbH

    Jaguar Land Rover and Gorillaz Seek New Engineering Talent via Alternate Reality

    Whitley, England (ots/PRNewswire) - - Jaguar Land Rover use new Gorillaz mixed reality app as innovative recruitment tool - App has a code-breaking challenge to test future engineering talent - Successful game players will be fast-tracked through Jaguar Land Rover's recruitment process - Global initiative aims to recruit more than 1,000 electronic and software ...

  • 12.04.2017 – 08:02

    Clearwater Seafoods Incorporated

    Clearwater Seafoods Expands European Arctic Surfclam Product Offerings With Sushi-Ready Slices

    Windsor, England (ots/PRNewswire) - Clearwater Seafoods announced today the launch of its 100% natural and wild-caught Arctic Surfclams in pre-cut and portioned sushi-ready slices to the European marketplace. Clearwater will showcase this new and convenient, ready-to-use clam format at Seafood Expo Global (SEG) taking place April 25-27 in Brussels, Belgium. "We're ...

  • 12.12.2016 – 08:01

    Astellas Pharma EMEA

    Astellas Announces Transfer of Qutenza(TM) to Grünenthal

    Tokyo and Chertsey, England (ots/PRNewswire) - Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka, "Astellas"), today announced that Astellas Pharma Europe Ltd., ("Astellas Pharma Europe") has entered into a definitive agreement with Grünenthal under which Astellas Pharma Europe will transfer the exclusive rights for Qutenza(TM) (capsaicin 8% patch) in Europe, Middle East and Africa to Grünenthal. (Logo: ...

  • 18.07.2016 – 12:16

    ViiV Healthcare

    ARIA Study Shows Superior Efficacy of Triumeq® for Treatment-naïve Women Living with HIV

    London, England and Durban, South Africa (ots/PRNewswire) - ViiV Healthcare today presented 48-week data from the phase IIIb, open-label, international, multi-centre ARIA study which showed superior efficacy for Triumeq® (dolutegravir/abacavir/lamivudine) compared with atazanavir boosted with ritonavir (ATV/r) plus tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) ...